Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metrix Healthcare India is an India-based pharmaceutical company focused on the manufacture, marketing, and export of a broad portfolio of finished-dose medicines and related healthcare products. The company presents itself as an ethical pharma business and PCD pharma franchise supplier, with products spanning antibiotics, cough and anti-allergic syrups, anti-inflammatory and analgesic medicines, antacids, antimalarials, injectables, vitamins and minerals, ayurvedic products, and oncology products. It states that its products are manufactured in WHO-GMP and Schedule-M approved facilities and that it operates under ISO 9001:2015 quality certification. Rather than a biotech innovator with a disclosed novel R&D pipeline, Metrix appears to be a commercial-stage branded generics and pharma marketing company serving India and export markets. The business is centered on product breadth, distribution, franchise partnerships, and manufacturing/vendor network execution rather than proprietary drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metrix.